-+ 0.00%
-+ 0.00%
-+ 0.00%

*Beam Therapeutics Ended 2Q 2026 With $1.2 B in Cash, Cash Equivalents and Marketable Securities >BEAM

Dow Jones·08/04/2026 11:00:00

Please log in to view news